ONKURE THERAPEUTICS, INC. Public Float
ONKURE THERAPEUTICS, INC. (OKUR) had Public Float of $28.00 million as of 2025-06-30, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-12
- 2025-06-30: Entity Public Float $28.00M.
- 2024-06-28: Entity Public Float $27.70M.
- 2023-06-30: Entity Public Float $151.40M.
- 2022-06-30: Entity Public Float $38.70M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $28.00M 10-K · filed 2026-03-12 |
| 2024-06-28 | $27.70M 10-K · filed 2025-03-10 |
| 2023-06-30 | $151.40M 10-K/A · filed 2024-04-26 |
| 2022-06-30 | $38.70M 10-K · filed 2023-03-27 |
| 2021-06-30 | $93.28M 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |